RxDoctor Payments DataLook up a doctor →

Ian Marshall, MD

Urology · Charleston, SCNPI 1255384053

Payments from drug & device makers

$60,103in general payments, 2019–2025

Across 649 payments — averaging $92.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$18K
  • Bayer$14K
  • Amgen$4K
  • AstraZeneca$4K
  • Janssen Global Services, LLC$3K
  • Boston Scientific$3K
  • plus $14K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson111$17,602
Bayer63$14,442
Amgen10$3,921
AstraZeneca19$3,726
Janssen Global Services, LLC2$3,283
Boston Scientific26$2,656
Pfizer25$1,642
Dendreon Pharmaceuticals LLC44$1,302
Procept Biorobotics Corporation16$1,287
Urogen Pharma, Inc.21$1,125
Astellas Pharma US Inc42$1,090
Accord Healthcare, Inc.3$786
Sumitomo Pharma America, Inc.25$785
Merck24$677
Teleflex LLC16$676
Coloplast21$500
Endo Pharmaceuticals Inc.20$449
AbbVie(2 entities)22$403
Progenics Pharmaceuticals, Inc.19$400
Angiodynamics, Inc.3$295
Verity Pharmaceuticals Inc.7$273
Sun Pharmaceutical Industries Inc.8$243
Antares Pharma, Inc.14$216
Medtronic3$206
Blue Earth Diagnostics7$166
Ferring Pharmaceuticals Inc.6$150
Olympus America Inc.5$132
Neotract Inc.3$131
Novartis6$131
Tolmar, Inc.4$124
Immunitybio, Inc.1$123
Foundation Medicine, Inc.2$102
Clarus Therapeutics Inc.5$78
Myovant Sciences Inc.4$71
Bioprotect Medical, Inc.2$68
Tempus AI, Inc2$58
Abbott2$51
Ambu Inc.3$50
Endo USA, Inc.2$47
Arrow International, Inc.3$47
Axonics, Inc.2$44
Stryker1$43
Fujifilm Healthcare Americas Corporation1$38
Urovant Sciences Inc2$37
Profound Medical Corp.2$37
Myriad Genetic Laboratories, Inc.2$35
Cardinal Health 108 LLC1$35
Telix Pharmaceuticals1$35
Civco Medical Instruments1$31
Avadel Specialty Pharmaceuticals, LLC2$31
Tolmar Pharmaceuticals, Inc.2$30
Laborie Medical Technologies Corp.2$30
Halozyme Inc1$23
Palette Life Sciences, Inc.1$23
Biotissue Holdings Inc.1$21
Provepharm Inc.1$17
RGH Enterprises LLC1$17
180 Medical, Inc.1$17
Janssen Scientific Affairs, LLC1$15
Smith+Nephew1$15

How this compares

$60,103 in reported general payments places this provider in the 90th percentile of 196 urology providers in South Carolina.

See all urology providers in South Carolina

Medicare billing

Part B allowed, 2024
$456,331
Medicare patients
732
Services billed
14,416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →